Alternaria species are ubiquitous dematiaceous fungi that are increasingly recognized as pathogens in immunocompromised patients or those with significant underlying disease, but they are also pathogens in otherwise healthy hosts. We describe a case of dermal cutaneous ulcerative alternariosis in a frail 83-year-old patient with diet-controlled diabetes mellitus. Histological analysis revealed hyphal morphology in tissue sections that was initially confused with that of a zygomycetous fungus, and multiple positive culture results were necessary to identify the organism. Treatment with oral itraconazole and surgical debridement were ineffective; clinical improvement was achieved by means of treatment with intravenous amphotericin B lipid complex. We review the literature regarding the role of diabetes mellitus in cutaneous alternariosis and regarding the efficacy of treatment with itraconazole, which has been used very successfully. To our knowledge, this is only the second case report noting diabetes mellitus uncomplicated by steroid administration as a possible predisposing factor for cutaneous infection.
immunologic impairment and far less often in healthy individuals.
We describe a case of cutaneous alternariosis in an elderly patient with diet-controlled diabetes mellitus. Infection was confirmed by histological examination and culture of a biopsy specimen. Treatment with itraconazole and surgical debridement was ineffective, and clinical resolution required antifungal therapy with amphotericin B lipid complex. Diabetes mellitus, considered by some investigators to represent an immunodeficient state [4] [5] [6] , is nonetheless infrequently cited in association with dermatologic alternariosis. It has been a decade since the last review of cutaneous alternariosis; during this time, itraconazole has become widely available and assumed a role in therapy for phaeohyphomycoses [7] . In addition to our case report, we review the literature regarding the role of diabetes mellitus in cutaneous alternariosis and the efficacy of treatment with itraconazole. Results of histopathological analysis of a punch biopsy specimen obtained on hospital day 4 from a patient with cutaneous ulcerative alternariosis in association with diabetes mellitus. A, Dermal fibrosis and round to oval, thick-walled fungal structures (arrows) with rare hyphal fragments (arrowhead; hematoxylin-eosin stain; original magnification, ϫ100). B, Narrow septate hypha (arrow; hematoxylin-eosin stain; original magnification, ϫ160).
CASE REPORT
An 83-year-old woman presented to her general practitioner in January 1999 with a 1-week history of a tender violaceous papule on the posterior aspect of the left lower extremity over the Achilles tendon region. Her medical history included dietcontrolled diabetes mellitus and atrial fibrillation complicated by a cerebral vascular accident with subtle residual left-side weakness. Previously, her diabetes had been controlled with glyburide, but as of 1998, it had been managed with diet alone. Random or fasting blood glucose levels measured from February through August 1999 ranged from 159 to 206 mg/dL. In January 1999, hemoglobin A 1C was mildly elevated at 7.4% (reference range, 4.5%-6.1%). The patient denied trauma or insect bite to the area. She was afebrile and had no systemic symptoms.
The patient was treated empirically with a 2-week course of cefazolin with little improvement and was referred for dermatologic consultation. Despite empirical treatment with an additional 2-week course of oral trovafloxacin, the lesion worsened with development of a central necrotic eschar. Concomitantly, the patient had progressive calf pain and difficulty walking. She was hospitalized for further diagnostic evaluation and therapeutic management.
At the time of admission to our center, the patient was a frail elderly woman of slight stature. She was afebrile (temperature, 37.2ЊC). The left lower extremity had a -cm 2.0 ϫ 2.0 shallow ulcer with central eschar formation and denuded tissue at the periphery. The perimeter of the lesion was violaceous and ecchymotic with a 4-to 6-cm radius (figure 1). The area was tender to touch without significant edema. No peripheral sensory loss was noted in the distal extremities. Bilateral pulses were graded as 1 to 2ϩ. There was no evidence of other skin lesions, venous stasis, or peripheral vascular disease. Laboratory studies disclosed the following values: WBC count, 6500 cells/ mm 3 (53% polymorphonuclear cells, 33% lymphocytes, 3% eosinophils, and 11% monocytes); blood urea nitrogen level, 30 mg/dL; creatinine level, 1.2 mg/dL; albumin level, 3.5 g/dL; and erythrocyte sedimentation rate, 38 mm/h. Glucose level at admission was 85 mg/dL. Cultures of blood samples obtained at the time of admission were negative for bacteria and fungi. A chest radiograph demonstrated no infiltrates or nodules. A tibia-fibula radiograph of the affected leg showed no evidence of periosteal reaction or osteomyelitis. Treatment with iv ticarcillin/clavulanate was initiated.
Punch biopsy of the leading edge of the lesion was performed on hospital day 4. Direct examination of the biopsy specimen with use of potassium hydroxide revealed no evidence of fungal infection. Histological analysis of the lateral margin of the biopsy specimen disclosed ulceration and underlying dermal fibrosis in which fungal structures were noted (figure 2A). Most of these structures were large, round to oval, thick-walled cells that were 11-22 mm in diameter. In addition, there were rare hyphal fragments of varying width (3-8 mm) . At this time, a diagnosis of zygomycotic infection was strongly considered because of the clinical situation (necrotic cutaneous ulcer in a diabetic patient) and the size of the hyphal fragments seen in the biopsy specimen. However, further histological examination also revealed hyphae with small diameters (3-5 mm) that had uniform walls and septation, findings that argued against zygomycotic infection (figure 2B).
Histological analyses of additional tissue sections of the biopsy specimen, including methenamine silver staining and periodic acid-Schiff staining, did not demonstrate hyphal forms. Fontana-Masson staining of decolorized hematoxylin-eosinstained tissue sections did not demonstrate the presence of melanin in hyphal cell walls. The conflicting appearance of fungal structures seen in tissue sections limited the correlation of morphological features with identification of a specific mycosis; therefore, a second biopsy was performed (hospital day 9). At the time of the second biopsy, full surgical excision of the lesion was not feasible because of the limitations of its location and the decreased body mass of the patient (although surgical debridement was performed). Hyphae morphologically similar to those seen in the first biopsy specimen were present on direct examination of a calcofluor-stained preparation, and hyphal septation was now more apparent (figure 3). Unfortunately, histological analysis of hematoxylin-eosin-stained tissue sections did not reveal fungal forms.
Cultures of the first biopsy specimen became positive for a nonzygomycetous fungus after 6 days (hospital day 10). Treatment with a cyclodextrin oral suspension of itraconazole (400 mg daily) was then initiated on the basis of the results of histological analyses and recovery of a nonzygomycetous fungus. Subsequent to initiation of antifungal therapy, the fungus isolated from the first biopsy specimen was identified as a member of the genus Alternaria. Cultures of the second biopsy specimen were also positive for Alternaria species after 4 days of incubation. Isolates from both biopsy specimens were identified as Alternaria alternata. Confirmatory identification to the species level and susceptibility testing were performed at the Fungus Testing Laboratory, University of Texas (San Antonio, TX). The fungus was susceptible to itraconazole (72-h MIC, 0.25 mg/mL) and amphotericin B (72-h MIC, 0.25 mg/mL).
Despite treatment for 23 days with an oral suspension of itraconazole (total dose, 7.8 g) and surgical debridement, the lesion progressed to deeper ulceration with an enlarging perimeter. An itraconazole level determined on hospital day 12 was supratherapeutic at 6.5 mg/mL (reference range, 0.1-2.2 mg/ mL). Itraconazole therapy was discontinued, and treatment with iv amphotericin B lipid complex (Abelcet; The Liposome Company; 4 mg/kg/d or 173 mg) was instituted (hospital day 33) and continued for 21 days (total dose, 3.63 g). Amphotericin B lipid complex was the preferred treatment because of the patient's frailty and concerns about renal insufficiency. Wound progression stabilized although significant improvement was not noted. Histological analysis and cultures of a follow-up biopsy specimen obtained on hospital day 53 were negative for fungi and other organisms. The patient underwent reparative skin grafting of her wound and was discharged with regular outpatient wound care management.
One month later, cultures of specimens from the wound site were again negative for fungi and other organisms. Slow improvement was noted with near complete resolution of the lesion on the left lower extremity by 3 months after discharge. The patient remained free of symptoms at her last follow-up 5 months after discharge.
DISCUSSION AND LITERATURE REVIEW
Dematiaceous fungi, like Alternaria, are characterized by the deposition of melanin in the cell wall. Melanin is thought to offer protection from environmental stress, such as radiation, temperature extremes, and hydrolytic enzymes, and to enhance the virulence and pathogenicity of some fungi [8] . The 3 most common fungal infections caused by dematiaceous fungi are phaeohyphomycosis, chromoblastomycosis, and mycetoma. As noted by McGinnis and Hilger [9] , Ajello advocated the term "phaeohyphomycosis" to describe infections caused by the presence in tissue of melanized hyphae, pseudohyphae, or yeastlike cells. This characteristic distinguishes phaeohyphomycosis from chromoblastomycosis with the presence of muriform cells and from eumycotic mycetomatous infections with pigmented granules. Alternaria is one of a group of ∼30 fungal genera that can cause phaeohyphomycosis. On the basis of clinical characteristics of infection, there are 4 types of phaeohyphomycosis: superficial, cutaneous, subcutaneous, and systemic with cutaneous and/or visceral involvement [9] .
Cutaneous alternariosis is characterized by hyphae that are limited to the superficial epidermis (epidermal type) or by dermal invasion by hyphae and thick-walled fungal cells (dermal type). Although there are case reports of clinically significant ungual and superficial epidermal alternariosis, most reports are of dermal cutaneous alternariosis. Because Alternaria can be a laboratory contaminant, histological confirmation is important to establish the clinical significance of a positive culture.
We reviewed the literature in English and other languages for reports of cases of histologically confirmed dermal cutaneous alternariosis. Before 1992, there were several reviews of cutaneous alternariosis [5, [10] [11] [12] [13] [14] . We evaluated these reviews, supplemented them with additional case reports published before 1992, and updated the world's literature for the past decade. This effort yielded reports of 89 cases that met both histological and culture criteria. There were 4 additional cases that were not available for review [15] [16] [17] [18] . In instances in which the isolate was identified to the species level, A. alternata was implicated in 28 cases; Alternaria tenuissima was implicated in 17 cases; and Alternaria chartarum, Alternaria longipes, Alternaria infectoria, Alternaria chlamydospora, Alternaria stemphyloides, and Alternaria dianthicola were implicated in 1 case each. In 38 cases of cutaneous alternariosis, the fungus was not identified to the species level.
The 89 cases of cutaneous alternariosis are summarized in tables 1 and 2. Most cases (73 [82%] ) occurred in patients with immunodeficiency and/or significant underlying disease. Most importantly, 52 (58.4%) of the 89 cases developed in the setting of systemic steroid administration. Nine additional cases were associated with endogenous hypercorticism (i.e., Cushing's disease or syndrome). There was only 1 case in addition to the present case where diabetes mellitus was unconfounded by concomitant steroid therapy.
Itraconazole was widely available for use by 1986. The drug was used for treatment in 15 (16.9%) of 89 cases of cutaneous alternariosis, including our case (table 3) . Only 3 (20%) of the 15 patients were immunocompetent. Eleven of the 12 immunocompromised patients developed alternariosis in the setting of steroid administration. Itraconazole was primary treatment in 10 cases, of which 9 (90%) resulted in clinical resolution or regression. Itraconazole was successful in 4 (26.7%) of 15 cases as secondary treatment after appropriate initial therapy failed. Three of these 4 patients were immunocompromised and required steroid treatment for their underlying illness. Despite this success rate, tapering of immunosuppressant doses [26, 45, 52, 58] , prolonged therapy (12 months) [3, 36, 42, 45, 52, 58, 68] , and, occasionally, increased dose and/or duration of treatment [36, 52] were required for eradication of disease. The average duration of therapy was 2.8 months (range, 2 weeks to 7 months), with dosages ranging from 100 mg to 600 mg/ d. Curiously, ours is the sole case in which itraconazole failed as primary therapy, in spite of in vitro susceptibility to this antifungal agent, use of cyclodextrin oral suspension, and documentation of adequate systemic absorption.
By comparison, amphotericin B in iv or intralesional form or in conjunction with other therapy and/or surgery was used in 13 of 89 cases; in 8 (61.5%) of 13, clinical resolution or regression was achieved [13, 30, 39, 41, 53, 72, 79] . There were no cases involving the use of lipid formulations of amphotericin B for comparison with these results or the results for our case. In the group of immunocompromised patients, 4 documented resolutions were associated with a decrease in steroid dose or treatment of an underlying disease, without concomitant antifungal therapy [62, 73, 77, 78] . Excisional therapy was effective as primary therapy alone in 2 cases [46, 50] . Spontaneous clinical resolution occurred only in 1 of 5 immunocompromised patients who received no therapeutic intervention [84] . The role of in vitro susceptibility testing and clinical correlation of these test results remain unclear. Although break points with clinical correlation have been established for yeast [91] , similar standards for filamentous fungi have not been well established.
Current dogma holds that diabetes significantly predisposes patients to fungal infections. Increased susceptibility to infections has been attributed to a variety of factors, including vascular disease, neuropathy, hyperglycemia, serum iron, leukocyte dysfunction, and poor wound healing. Although fungal infections have been frequently described in the diabetic host, Vazquez and Sobel [6] found an increased frequency of mycotic infection limited to various manifestations of candidiasis and rhinocerebral zygomycosis. In a recent population-based epidemiological study by Rees et al. [92] , diabetes mellitus was cited as the third most common underlying condition associated with all types of invasive mycoses. Diabetes was also found in 10 of 30 patients identified who had less common mycoses, including phaeohyphomycosis. In this group, 3 of 6 patients with phaeohyphomycosis had diabetes mellitus.
In contrast, our review of the literature found cutaneous phaeohyphomycotic infections (mostly those due to genera other than Alternaria) to be infrequently reported in association with diabetes. We found only 1 other histologically and culturally confirmed case of cutaneous alternariosis that identified diabetes mellitus as a predisposing factor [82] . As in our case, the patient was a woman with mild diabetes who presented with a several-month history of chronic lesions on an extremity but no substantiated history of antecedent trauma. The investigators noted this as the first reported case of a patient with diabetes mellitus and alternariosis, and they suggested that diabetes contributes to the predisposition to infections, as noted previously for phaeomycotic cysts [4] . Control of the glucose level and prolonged oral and topical antifungal therapy successfully resolved the lesion. Three additional patients with a history of diabetes mellitus had clinical courses confounded by associated steroid administration [66, 78] . Although the literature does not provide evidence that diabetes mellitus is a factor frequently associated with development of cutaneous alternariosis, the possibility of such infection should remain in the differential diagnosis when diabetic patients who are suspected of having fungal disease are evaluated.
Recognition of Alternaria as a potential opportunistic pathogen is important for the differential diagnosis of dermatologic lesions. The clinical manifestations of cutaneous alternariosis vary greatly. Lesions can appear as shallow-based nonhealing ulcers that evolve from nodules, subcutaneous noninflammatory cysts, verrucous-like lesions, or erythematous, confluent, scaly patches. Histologically, variation of the host response and of the morphological appearance of hyphae in tissue creates the potential for diagnostic confusion. A mixed inflammatory dermal infiltrate (neutrophils, lymphocytes, and plasma cells) is typically seen with or without giant cells and histiocytes. Microabscesses and/or well-formed granulomas may also be present. Fungal morphology is pleomorphic, ranging from globose cells to distorted hyphae with a variable frequency of septation and branching [10-12, 27-29, 55] .
Hyphae of hyalohyphomycetes (e.g., Aspergillus species) and zygomycetes (e.g., Rhizopus species) can be confused with those of Alternaria species and other dematiaceous fungi [1, 2, 28] . This confusion was especially evident in our case: initial clinical concern about zygomycosis was greater after the observation of wide hyphal fragments with nonuniform diameters and bulbous areas. Septate hyphae with narrow uniform diameters, also seen in our patient's biopsy specimen, were more consistent with phaeohyphomycosis or hyalohyphomycosis than with zygomycosis. Our consideration of dematiaceous mycosis was further confounded by the absence of melanin in hyphal cell walls in Fontana-Masson-stained tissue sections. Fontana-Masson staining is a useful differential procedure, although some investigators have noted inconsistent results in cases of phaeohyphomycoses; therefore, negative staining results should not preclude consideration of a dematiaceous organism [26, 28, 29, 93] , which is important because histological evaluation has implications for initiation of antifungal therapy before confirmation by culture. Empirical treatment with itraconazole may be substituted once zygomycosis is ruled out. This was an important consideration for our frail elderly patient with mild renal insufficiency, for whom amphotericin B was not the first choice of treatment because of its renal toxicity and because of concerns about the necessity of extended hospitalization.
The treatment of cutaneous alternariosis and appropriate antifungal dosages have not been standardized, and these issues have not been specifically addressed in the literature. In a 1990 review of 17 cases of phaeohyphomycosis, Sharkey et al. [7] advocated itraconazole as the treatment of choice for cutaneous and extracutaneous disease. However, in this review, there were only 4 cases of phaeohyphomycosis limited to skin and/or soft tissue, and none were caused by Alternaria. Our review found 89 cases of histologically and culturally confirmed dermal cutaneous alternariosis, and in 15 of these cases, itraconazole was used as primary or secondary therapy. Resolution of lesions was documented in 14 (93.3%) of 15 cases, thereby supporting the efficacy of itraconazole in the treatment of cutaneous alternariosis.
The reason for failure of itraconazole treatment in our patient, despite adequate levels in serum, is unclear. Subtherapeutic tissue concentrations at the site of infection in a diabetic patient is conceivable. Parenteral itraconazole formulation (unavailable at the time of our patient's presentation) might have achieved higher tissue concentrations, thus altering the clinical outcome. In addition, results of susceptibility testing may not be predictive of clinical responsiveness. We found that amphotericin B has also been used with relative success, with and without other therapeutic measures. There is essentially no information regarding the use of lipid formulations of amphotericin B. There is a perception in the literature that treatment of cutaneous phaeohyphomycoses, including alternariosis, can be difficult and frustrating because of a propensity for relapse. Our review of the literature revealed only 6 definitive relapses. Of note, one-half of the cases of relapse occurred in immunocompetent hosts [19, 27, 36] , and the other one-half occurred in immunosuppressed hosts [29, 48, 56] . In spite of the numbers, prolongation of therapy after clinical resolution and long-term follow-up seem to be prudent during the management of cutaneous alternariosis.
SUMMARY
Alternaria is a fungus that can cause cutaneous lesions that require surgical debridement and prolonged antifungal therapy. Alternaria is often an opportunistic pathogen in immunocompromised hosts, but it is also important to recognize the potential of this fungus as a pathogen in the immunocompetent host. Although diabetes mellitus is infrequently cited as a predisposing factor for Alternaria infection, it and advanced age are 2 factors that may explain our patient's initial infection. Multiple positive culture results and identification of fungal elements during direct examination of specimens or in tissue sections are crucial in distinguishing cases of infection from cases of contamination. Hyphal morphology in histological sections can be misleading or nonspecific, which also underscores the importance of culture and correct identification of the organism. In our case, the role of antifungal therapy assumed greater importance because surgical resection was limited by the location of the lesion and the patient's frailty.
Review of the literature on cutaneous alternariosis suggests that itraconazole is the preferred drug of choice. However, amphotericin B has also been used successfully, and in our case, this drug was necessary to achieve clinical resolution without relapse during a 5-month follow-up. Whether the lipid formulation of amphotericin B was necessary is unknown. The role of in vitro susceptibility testing and clinical correlation of these test results remain unclear, as illustrated by our case where the isolate was susceptible to both itraconazole and amphotericin B. As is true for many patients with cutaneous alternariosis, our patient had prolonged infection that required vigilant management and extended follow-up to monitor for recurrence of infection.
